|
|
Name: |
BAKER BROS ADVISORS LLC |
City: |
NEW YORK |
State: |
NY |
Zip: |
10021 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
53 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
BGNE |
Beigene Ltd |
2 |
- |
$167.92 |
$1,652,870,000 |
10,568,897 |
20.73% |
-253,336,000 |
0 |
11.662 |
N/A |
|
ACAD |
Acadia Pharmaceuticals Inc |
3 |
- |
$15.82 |
$792,567,000 |
42,864,612 |
9.94% |
-549,524,000 |
0 |
26.664 |
Biotechnology |
|
MDGL |
Madrigal Pharmaceuticals Inc |
4 |
- |
$235.06 |
$526,015,000 |
1,969,798 |
6.6% |
70,243,000 |
0 |
9.979 |
Diagnostic Substances |
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
5 |
- |
$37.84 |
$277,241,000 |
6,398,365 |
3.48% |
-16,892,000 |
0 |
9.02 |
N/A |
|
KYMR |
Kymera Therapeutics, Inc. |
7 |
- |
$0.00 |
$241,036,000 |
5,995,928 |
3.02% |
88,380,000 |
0 |
9.618 |
N/A |
|
KOD |
Kodiak Sciences Inc. |
12 |
- |
$3.26 |
$91,053,000 |
17,310,490 |
1.14% |
38,429,000 |
0 |
38.64 |
N/A |
|
REPL |
Replimune Group Inc |
14 |
- |
$5.93 |
$77,985,000 |
9,545,336 |
0.98% |
-2,482,000 |
0 |
15.549 |
N/A |
|
TRDA |
Entrada Therapeutics, Inc. |
16 |
- |
$0.00 |
$68,949,000 |
4,865,819 |
0.86% |
-4,476,000 |
0 |
15.59 |
N/A |
|
RARE |
Ultragenyx Pharmaceutical Inc |
18 |
- |
$41.08 |
$68,473,000 |
1,466,547 |
0.86% |
-1,657,000 |
0 |
1.786 |
Restaurants |
|
CERE |
Cerevel Therapeutics Holdin... |
20 |
- |
$41.65 |
$67,632,000 |
1,600,000 |
0.85% |
-208,000 |
0 |
1.024 |
N/A |
|
ARGX |
Argenx Se |
21 |
- |
$363.73 |
$59,536,000 |
151,215 |
0.75% |
2,009,000 |
0 |
0.322 |
N/A |
|
NRIX |
Nurix Therapeutics, Inc. |
22 |
- |
$0.00 |
$57,067,000 |
3,882,125 |
0.72% |
17,003,000 |
0 |
8.253 |
N/A |
|
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
23 |
- |
$19.27 |
$55,433,000 |
2,809,577 |
0.7% |
6,153,000 |
0 |
7.934 |
N/A |
|
BCRX |
Biocryst Pharmaceuticals Inc |
24 |
- |
$6.66 |
$51,441,000 |
10,126,176 |
0.65% |
-9,215,000 |
0 |
5.344 |
Biotechnology |
|
AVTE |
Aerovate Therapeutics, Inc. |
25 |
- |
$0.00 |
$49,693,000 |
1,680,517 |
0.62% |
11,663,000 |
0 |
6.073 |
N/A |
|
SERA |
Sera Prognostics, Inc. |
26 |
- |
$8.20 |
$49,453,000 |
5,434,399 |
0.62% |
16,955,000 |
0 |
18.554 |
N/A |
|
PRLD |
Prelude Therapeutics Inc |
27 |
- |
$0.00 |
$47,987,000 |
10,123,824 |
0.6% |
4,758,000 |
0 |
23.167 |
N/A |
|
IDYA |
Ideaya Biosciences, Inc. |
28 |
- |
$0.00 |
$46,606,000 |
1,062,123 |
0.58% |
8,816,000 |
0 |
1.473 |
N/A |
|
XENE |
Xenon Pharmaceuticals Inc. |
30 |
- |
$0.00 |
$42,778,000 |
993,679 |
0.54% |
-2,991,000 |
0 |
1.32 |
N/A |
|
CERS |
Cerus Corp |
32 |
- |
$1.93 |
$36,812,000 |
19,477,339 |
0.46% |
-5,259,000 |
0 |
11.653 |
Biotechnology |
|
GLUE |
Monte Rosa Therapeutics, Inc. |
33 |
- |
$0.00 |
$34,658,000 |
4,916,095 |
0.43% |
6,882,000 |
0 |
11.05 |
N/A |
|
BMEA |
Biomea Fusion, Inc. |
35 |
- |
$11.50 |
$31,529,000 |
2,108,949 |
0.4% |
907,000 |
0 |
7.33 |
N/A |
|
KRYS |
Krystal Biotech Inc |
36 |
- |
$169.25 |
$30,236,000 |
169,934 |
0.38% |
9,154,000 |
0 |
0.682 |
N/A |
|
VERV |
Verve Therapeutics, Inc. |
39 |
- |
$0.00 |
$22,464,000 |
1,691,530 |
0.28% |
-1,116,000 |
0 |
2.103 |
N/A |
|
TCRX |
Tscan Therapeutics, Inc. |
40 |
- |
$0.00 |
$22,111,000 |
2,784,792 |
0.28% |
5,876,000 |
0 |
6.394 |
N/A |
|
IMVT |
Immunovant Inc |
42 |
- |
$0.00 |
$13,732,000 |
425,009 |
0.17% |
-4,174,000 |
0 |
0.488 |
N/A |
|
TSVT |
2seventy Bio, Inc. |
43 |
- |
$0.00 |
$13,362,000 |
2,497,526 |
0.17% |
2,698,000 |
0 |
4.807 |
N/A |
|
TSHA |
Taysha Gene Therapies, Inc. |
46 |
- |
$0.00 |
$11,494,000 |
4,004,756 |
0.14% |
4,406,000 |
0 |
2.142 |
N/A |
|
DBVT |
DBV Technologies SA |
47 |
- |
$0.62 |
$10,948,000 |
14,614,264 |
0.14% |
-2,976,000 |
0 |
13.329 |
N/A |
|
CLDX |
Celldex Therapeutics Inc |
48 |
- |
$38.10 |
$10,394,000 |
247,644 |
0.13% |
572,000 |
0 |
0.394 |
Diagnostic Substances |
|
RLAY |
Relay Therapeutics, Inc. |
49 |
- |
$7.53 |
$9,629,000 |
1,160,117 |
0.12% |
-3,144,000 |
0 |
0.857 |
N/A |
|
INSM |
Insmed Inc |
50 |
- |
$24.16 |
$9,306,000 |
343,000 |
0.12% |
-1,324,000 |
0 |
0.226 |
Biotechnology |
|
ATHA |
Athira Pharma, Inc. |
53 |
- |
$0.00 |
$8,641,000 |
3,153,807 |
0.11% |
977,000 |
0 |
10.233 |
N/A |
|
PRAX |
Praxis Precision Medicines,... |
55 |
- |
$0.00 |
$8,026,000 |
131,533 |
0.1% |
5,095,000 |
0 |
0.251 |
N/A |
|
PRME |
Prime Medicine, Inc. |
58 |
- |
$7.45 |
$7,199,000 |
1,028,466 |
0.09% |
-1,913,000 |
0 |
1.058 |
N/A |
|
TNGX |
Tango Therapeutics Ord Shs |
60 |
- |
$0.00 |
$5,955,000 |
750,000 |
0.07% |
-1,470,000 |
0 |
0.735 |
N/A |
|
HOOK |
Hookipa Pharma Inc. |
61 |
- |
$0.00 |
$5,787,000 |
8,128,151 |
0.07% |
-797,000 |
0 |
15.975 |
N/A |
|
MRSN |
Mersana Therapeutics, Inc. |
62 |
- |
$2.57 |
$4,866,000 |
1,086,115 |
0.06% |
2,346,000 |
0 |
0.901 |
N/A |
|
MIRM |
Mirum Pharmaceuticals, Inc. |
63 |
- |
$0.00 |
$4,785,000 |
190,476 |
0.06% |
-838,000 |
0 |
0.355 |
N/A |
|
TLIS |
Talis Biomedical Corp |
64 |
- |
$0.00 |
$4,448,000 |
508,323 |
0.06% |
661,000 |
0 |
2.165 |
N/A |
|
PCVX |
Vaxcyte, Inc. |
65 |
- |
$0.00 |
$3,339,000 |
48,885 |
0.04% |
269,000 |
0 |
0.045 |
N/A |
|
IPSC |
Century Therapeutics, Inc. |
66 |
- |
$0.00 |
$3,333,000 |
797,460 |
0.04% |
685,000 |
0 |
1.455 |
N/A |
|
LPTX |
Leap Therapeutics, Inc. |
69 |
- |
$2.50 |
$3,118,000 |
1,172,175 |
0.04% |
-1,741,000 |
0 |
1.965 |
N/A |
|
CMPX |
Compass Therapeutics Ord Shs |
70 |
- |
$0.00 |
$3,084,000 |
1,557,630 |
0.04% |
654,000 |
0 |
1.589 |
N/A |
|
KALA |
Kala Pharmaceuticals, Inc. |
73 |
- |
$6.51 |
$2,125,000 |
266,613 |
0.03% |
259,000 |
0 |
17.563 |
N/A |
|
ALGS |
Aligos Therapeutics, Inc. |
74 |
- |
$0.00 |
$2,035,000 |
2,076,400 |
0.03% |
656,000 |
0 |
2.883 |
N/A |
|
PFE |
Pfizer Inc |
79 |
- |
$29.60 |
$971,000 |
35,000 |
0.01% |
-37,000 |
0 |
0.001 |
Drug Manufacturers - ... |
|
TARA |
Protara Therapeutics, Inc |
80 |
- |
$2.99 |
$801,000 |
199,671 |
0.01% |
427,000 |
0 |
1.9 |
N/A |
|
PMVP |
Pmv Pharmaceuticals, Inc. |
81 |
- |
$0.00 |
$547,000 |
322,024 |
0.01% |
-451,000 |
0 |
0.592 |
N/A |
|
FHTX |
Foghorn Therapeutics Inc. |
83 |
- |
$0.00 |
$302,000 |
45,027 |
0% |
12,000 |
0 |
0.122 |
N/A |
|
CABA |
Cabaletta Bio, Inc. |
84 |
- |
$0.00 |
$227,000 |
13,331 |
0% |
-76,000 |
0 |
0.026 |
N/A |
|
TYRA |
Tyra Biosciences, Inc. |
86 |
- |
$0.00 |
$174,000 |
10,607 |
0% |
27,000 |
0 |
0.026 |
N/A |
|
SRZNW |
Surrozen Equity Warrant Exp... |
87 |
- |
$0.00 |
$25,000 |
833,333 |
0% |
9,000 |
0 |
9.259 |
N/A |
|